{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:06:32Z","timestamp":1775552792980,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004726","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ijcard.2019.04.066","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T18:13:41Z","timestamp":1556302421000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial"],"prefix":"10.1016","volume":"288","author":[{"given":"Vidal","family":"Essebag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"AlTurki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff S.","family":"Healey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher S.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Ayala-Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Coutu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Leather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish","family":"Toal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Sapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcio","family":"Sturmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago L.L.","family":"Leiria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colette","family":"Seifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Birnie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijcard.2019.04.066_bb0005","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1540-8159.2011.03150.x","article-title":"The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009\u2013a World Society of Arrhythmia's project","volume":"34","author":"Mond","year":"2011","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2019.04.066_bb0010","doi-asserted-by":"crossref","unstructured":"Nichols CI, Vose JG. Incidence of bleeding-related complications during primary implantation and replacement of cardiac implantable electronic devices. J. Am. Heart Assoc. 2017;6(1).","DOI":"10.1161\/JAHA.116.004263"},{"issue":"11","key":"10.1016\/j.ijcard.2019.04.066_bb0015","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jacc.2016.01.009","article-title":"Clinically significant pocket hematoma increases long-term risk of device infection: BRUISE CONTROL INFECTION study","volume":"67","author":"Essebag","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"20","key":"10.1016\/j.ijcard.2019.04.066_bb0020","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/archinternmed.2011.441","article-title":"Mortality and cost associated with cardiovascular implantable electronic device infections","volume":"171","author":"Sohail","year":"2011","journal-title":"Arch. Intern. Med."},{"issue":"10","key":"10.1016\/j.ijcard.2019.04.066_bb0025","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/europace\/euv075","article-title":"Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortality: a population-based study","volume":"17","author":"Sridhar","year":"2015","journal-title":"Europace."},{"issue":"12","key":"10.1016\/j.ijcard.2019.04.066_bb0030","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.jacc.2006.02.049","article-title":"The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators","volume":"47","author":"Reynolds","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2019.04.066_bb0035","first-page":"1461","article-title":"Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies","volume":"19","author":"Proietti","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.ijcard.2019.04.066_bb0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCEP.108.795906","article-title":"Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial","volume":"2","author":"de Oliveira","year":"2009","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"3","key":"10.1016\/j.ijcard.2019.04.066_bb0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.joa.2015.12.003","article-title":"Management of antithrombotic therapy during cardiac implantable device surgery","volume":"32","author":"AlTurki","year":"2016","journal-title":"J. Arrhythm."},{"issue":"9","key":"10.1016\/j.ijcard.2019.04.066_bb0050","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.hrthm.2009.05.027","article-title":"Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: wide variability of perioperative bridging in Canada","volume":"6","author":"Krahn","year":"2009","journal-title":"Heart Rhythm."},{"issue":"22","key":"10.1016\/j.ijcard.2019.04.066_bb0055","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","article-title":"Pacemaker or defibrillator surgery without interruption of anticoagulation","volume":"368","author":"Birnie","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ijcard.2019.04.066_bb0060","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.jacc.2009.12.056","article-title":"Dual antiplatelet therapy and heparin \"bridging\" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation","volume":"55","author":"Tompkins","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2019.04.066_bb0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/pace.12557","article-title":"Meta-analysis of continuous oral anticoagulants versus heparin bridging in patients undergoing CIED surgery: reappraisal after the BRUISE study","volume":"38","author":"Sant'anna","year":"2015","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2019.04.066_bb0070","doi-asserted-by":"crossref","first-page":"j3782","DOI":"10.1136\/bmj.j3782","article-title":"Indications for anticoagulant and antiplatelet combined therapy","volume":"359","author":"Floyd","year":"2017","journal-title":"BMJ."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2019.04.066_bb0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1538-7836.2007.02499.x","article-title":"Combined antiplatelet and anticoagulant therapy: clinical benefits and risks","volume":"5","author":"Eikelboom","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"38","key":"10.1016\/j.ijcard.2019.04.066_bb0080","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.04.066_bb0085","doi-asserted-by":"crossref","unstructured":"Lip GYH, Collet JP, Caterina R, Fauchier L, Lane DA, Larsen TB, et al. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). Europace. 2017;19(11):1757\u20131758.","DOI":"10.1093\/europace\/eux240"},{"issue":"10","key":"10.1016\/j.ijcard.2019.04.066_bb0090","first-page":"1170","article-title":"2016 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation","volume":"32","author":"Macle","year":"2016","journal-title":"Can. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2019.04.066_bb0095","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/HCO.0b013e32831bef53","article-title":"Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design","volume":"24","author":"Birnie","year":"2009","journal-title":"Curr. Opin. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2019.04.066_bb0100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2019.04.066_bb0105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/hc0502.103329","article-title":"Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study","volume":"105","author":"Fiore","year":"2002","journal-title":"Circulation."},{"issue":"13","key":"10.1016\/j.ijcard.2019.04.066_bb0110","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Warfarin, aspirin, or both after myocardial infarction","volume":"347","author":"Hurlen","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.04.066_bb0115","article-title":"Canadian stroke best practice recommendations: secondary prevention of stroke, sixth edition practice guidelines, update 2017","volume":"1747493017743062","author":"Wein","year":"2017","journal-title":"Int. J. Stroke"},{"issue":"9","key":"10.1016\/j.ijcard.2019.04.066_bb0120","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J."},{"issue":"7","key":"10.1016\/j.ijcard.2019.04.066_bb0125","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke."},{"issue":"5","key":"10.1016\/j.ijcard.2019.04.066_bb0130","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1161\/01.CIR.83.5.1526","article-title":"Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study","volume":"83","author":"Gavaghan","year":"1991","journal-title":"Circulation."},{"issue":"21","key":"10.1016\/j.ijcard.2019.04.066_bb0135","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2019.04.066_bb0140","first-page":"214","article-title":"2018 Canadian Cardiovascular Society\/Canadian Association of interventional cardiology focused update of the guidelines for the use of antiplatelet therapy","volume":"34","author":"Mehta","year":"2018","journal-title":"Can. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2019.04.066_bb0145","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.CIR.77.6.1324","article-title":"Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative study","volume":"77","author":"Goldman","year":"1988","journal-title":"Circulation."},{"issue":"7","key":"10.1016\/j.ijcard.2019.04.066_bb0150","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/CIRCULATIONAHA.113.002927","article-title":"Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry","volume":"128","author":"Steinberg","year":"2013","journal-title":"Circulation."},{"issue":"1","key":"10.1016\/j.ijcard.2019.04.066_bb0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11239-016-1425-5","article-title":"Combined aspirin and anticoagulant therapy in patients with atrial fibrillation","volume":"43","author":"So","year":"2017","journal-title":"J. Thromb. Thrombolysis"},{"issue":"11","key":"10.1016\/j.ijcard.2019.04.066_bb0160","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.11.008","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2019.04.066_bb0165","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1503\/cmaj.131568","article-title":"Deprescribing: a new word to guide medication review","volume":"186","author":"Frank","year":"2014","journal-title":"CMAJ."},{"issue":"3","key":"10.1016\/j.ijcard.2019.04.066_bb0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4212\/cjhp.v66i3.1261","article-title":"Deprescribing: what is it and what does the evidence tell us?","volume":"66","author":"Thompson","year":"2013","journal-title":"Can. J. Hosp. Pharm."},{"key":"10.1016\/j.ijcard.2019.04.066_bb0175","doi-asserted-by":"crossref","first-page":"i2893","DOI":"10.1136\/bmj.i2893","article-title":"Too much medicine in older people? Deprescribing through shared decision making","volume":"353","author":"Jansen","year":"2016","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.ijcard.2019.04.066_bb0180","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/archinte.164.7.785","article-title":"The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry","volume":"164","author":"Bobb","year":"2004","journal-title":"Arch. Intern. Med."},{"issue":"10","key":"10.1016\/j.ijcard.2019.04.066_bb0185","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/jama.293.10.1223","article-title":"Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review","volume":"293","author":"Garg","year":"2005","journal-title":"JAMA."},{"issue":"16","key":"10.1016\/j.ijcard.2019.04.066_bb0190","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJMoa1401105","article-title":"Aspirin in patients undergoing noncardiac surgery","volume":"370","author":"Devereaux","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.04.066_bb0195","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijcard.2016.03.008","article-title":"Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: insights from the J-RHYTHM Registry","volume":"212","author":"Watanabe","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2019.04.066_bb0200","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1016\/j.ijcard.2013.06.022","article-title":"Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment--the FinPAC study","volume":"168","author":"Airaksinen","year":"2013","journal-title":"Int. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319304140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319304140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:43:08Z","timestamp":1759092188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527319304140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":40,"alternative-id":["S0167527319304140"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.04.066","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.04.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}